반응식
[CH3:1][CH:2]1[S:7][C:6](=[O:8])[NH:5][N:4]=[C:3]1[C:9]1[CH:10]=[C:11]2[C:15](=[CH:16][CH:17]=1)[NH:14][C:13](=[O:18])[C:12]2=[N:19]C1C=CC=CC=1.[CH:26]1([NH:32]N)[CH2:31][CH2:30][CH2:29][CH2:28][CH2:27]1>>[CH:26]1([NH:32][N:19]=[C:12]2[C:11]3[C:15](=[CH:16][CH:17]=[C:9]([C:3]4[CH:2]([CH3:1])[S:7][C:6](=[O:8])[NH:5][N:4]=4)[CH:10]=3)[NH:14][C:13]2=[O:18])[CH2:31][CH2:30][CH2:29][CH2:28][CH2:27]1참가 물질
3
실험 절차
Starting from 1,3-dihydro-5-(3,6-dihydro-6-methyl-2-oxo -2H-1,3,4-thiadiazin-5-yl)-3-phenylimino-2H-indol-2-one, and cyclohexylhydrazine and following the method described in Example 21, the desired compound was obtained.
출처 및 근거
- ORD 기록
- ord-f583ee97f6724d12a4a2fc4424d08bab
- 출처 데이터셋
- uspto-grants-1991_09
- 특허 번호
- US05051417
연결된 노트
불러오는 중…